Multiple endocrine neoplasia type 2: achievements and current challenges
Incremental advances in medical technology, such as the development of sensitive hormonal assays for routine clinical care, are the drivers of medical progress. This principle is exemplified by the creation of the concept of multiple endocrine neoplasia type 2, encompassing medullary thyroid cancer,...
Main Authors: | Andreas Machens, Henning Dralle |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier España
2012-01-01
|
Series: | Clinics |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322012001300019 |
Similar Items
-
Genotype-phenotype correlation in multiple endocrine neoplasia type 2
by: Friedhelm Raue, et al.
Published: (2012-01-01) -
Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter study
by: Louise Vølund Larsen, et al.
Published: (2020-06-01) -
Multiple endocrine neoplasia type 2 – solving the puzzle
by: Ajay K Jha, et al.
Published: (2023-01-01) -
Surgical treatment of a patient with multiple endocrine neoplasia type 2A
by: T. A. Britvin, et al.
Published: (2020-11-01) -
Does Genotype-Specific Phenotype in Patients with Multiple Endocrine Neoplasia Type 2 Occur as Current Guidelines Predict?
by: Teresa Binter, et al.
Published: (2024-01-01)